Lite Strategy, Inc. NASDAQ: LITS has authorised a 25 million share repurchase programme. The decision was approved by its Board of Directors. It signals a major shift in how the company manages its digital asset treasury.
Lite Strategy is the first U.S.-listed company to hold Litecoin as its primary reserve asset. It was formerly known as MEI Pharma. After years focused on drug development, it now centres its business around digital asset management. The new buyback programme strengthens this new identity.
Under the plan, Lite Strategy can buy shares in the open market or through negotiated transactions. The move provides flexibility to manage capital more efficiently. It also gives the firm an additional tool to enhance shareholder value.
